Cargando…
Growth hormone treatment in non-growth hormone-deficient children
Until 1985 growth hormone (GH) was obtained from pituitary extracts, and was available in limited amounts only to treat severe growth hormone deficiency (GHD). With the availability of unlimited quantities of GH obtained from recombinant DNA technology, researchers started to explore new modalities...
Autores principales: | Loche, Sandro, Carta, Luisanna, Ibba, Anastasia, Guzzetti, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pediatric Endocrinology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049545/ https://www.ncbi.nlm.nih.gov/pubmed/24926456 http://dx.doi.org/10.6065/apem.2014.19.1.1 |
Ejemplares similares
-
SUN-256 Limited Usefulness of Single IGF-I Measurement as a Screening Test for Growth Hormone Deficiency in Children and Adolescents
por: Ibba, Anastasia, et al.
Publicado: (2019) -
IGF1 for the diagnosis of growth hormone deficiency in children and adolescents: a reappraisal
por: Ibba, Anastasia, et al.
Publicado: (2020) -
Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS)
por: Centonze, C., et al.
Publicado: (2019) -
SAT-253 Association between TSH and Cardiovascular Risk Parameters in Obese Children and Adolescents
por: Guzzetti, Chiara, et al.
Publicado: (2019) -
Cardiovascular Risk Factors in Children and Adolescents With Obesity: Sex-Related Differences and Effect of Puberty
por: Guzzetti, Chiara, et al.
Publicado: (2019)